Related Experiment Video
Updated: Jul 3, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain
Abstract:
The Mdmx oncoprotein has only recently emerged as a critical-independent to Mdm2-regulator of p53 activation. We have determined the crystal structure of the N-terminal domain of human Mdmx bound to a 15-residue transactivation domain peptide of human p53. The structure shows why antagonists of the Mdm2 binding to p53 are ineffective in the Mdmx-p53 interaction.
Insights
Mdmx, a regulator of p53, interacts differently with p53 than Mdm2. Understanding this Mdmx-p53 structure explains why Mdm2 inhibitors fail against Mdmx.
Area of Science:
- Molecular Biology
- Structural Biology
- Oncology
Background:
- Mdmx is an oncoprotein regulating p53 activation, independent of Mdm2.
- p53 is a tumor suppressor protein crucial for cellular response to stress.
Discussion:
- The crystal structure of human Mdmx N-terminal domain bound to a p53 peptide was determined.
- This structure reveals the molecular basis for the Mdmx-p53 interaction.
- It explains the ineffectiveness of Mdm2-targeting antagonists against Mdmx.
Key Insights:
- Mdmx and Mdm2 bind to p53 through distinct mechanisms.
- The unique Mdmx-p53 interface is a novel target for cancer therapy.
- Structural insights guide the development of specific Mdmx inhibitors.
Outlook:
- Further structural studies of Mdmx complexes.
- Development of novel therapeutics targeting the Mdmx-p53 interaction.
- Investigating Mdmx's role in various cancers.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Master Transcription Regulators
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

